Merkley: Supreme Court Decision Temporarily Preserves Mifepristone Access in Ongoing Fight for Reproductive Care

Washington, D.C. – Oregon’s U.S. Senator Jeff Merkley today issued the following statement after the Supreme Court’s unanimous decision in FDA v. Alliance for Hippocratic Medicine:

“Mifepristone has been approved by the U.S. Food and Drug Administration (FDA) since 2000 and has been used safely and effectively for decades. Today, the Supreme Court unanimously ruled that extremist groups trying to block access to this essential medication lacked standing—welcome news that preserves access to mifepristone. This is a win for reproductive freedom across America.

“This case was pushed by anti-abortion extremists who were ultimately found to have no legal standing to challenge access to this essential medication. While today’s decision did not undermine a federal agency’s science-based approval process, reproductive care remains under attack in states across America, and nothing is stopping other extremists from bringing similar cases before the Court. With Americans’ rights and freedoms at stake, I’ll keep fighting to protect access to the care all people need—including abortion—in Oregon and the rest of the nation.”